according to the Food and Drug Administration (FDA), as regulators await data on safety, efficacy and dosing.The Pfizer COVID-19 vaccine won full FDA approval on Monday for individuals 16 years and up, and in May the shot saw expanded emergency approval for use among adolescents ages 12-15.
Children ages 8 and older may become eligible for vaccinations by September, sources previously told FOX News."Ordinarily, as you know, when a medical product is approved, physicians often do use off-label prescribing," Dr.
Janet Woodcock, acting FDA commissioner, told reporters over a call Monday. "However this is a different situation. The vaccine is being distributed under provider agreement by the U.S.